Long-Term Exposure to Wildfire PM2.5 Tied to Higher Odds of Dementia

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 25, 2024 -- Long-term exposure to wildfire and nonwildfire fine particulate matter (PM2.5) is associated with increased odds of dementia diagnosis, according to a study published online Nov. 25 in JAMA Neurology.

Holly Elser, M.D., Ph.D., from the University of Pennsylvania in Philadelphia, and colleagues examined the association between long-term wildfire and nonwildfire PM2.5 exposure and the risk for incident dementia in an open cohort study conducted using January 2008 to December 2019 electronic health record data among members of Kaiser Permanente Southern California (KPSC) aged 60 years or older.

Overall, 1,223,107 KPSC members (53.0 percent female) were eligible for inclusion in the study. Of the participants, 26.0 and 49.0 percent identified as Hispanic and non-Hispanic White, respectively. During follow-up, 6.6 percent of participants received a dementia diagnosis. In adjusted models, the researchers observed an association for a 1-µg/m3 increase in the three-year mean of wildfire PM2.5 exposure with significantly increased odds of a dementia diagnosis (odds ratio, 1.18). A 1-µg/m3 increase in the three-year mean of nonwildfire PM2.5 exposure was associated with a smaller, but still statistically significant, increase in the odds of dementia diagnosis (odds ratio, 1.01). For wildfire PM2.5 exposure, members younger than 75 years upon cohort entry, members from racially minoritized subgroups, and those living in high- versus low-poverty census tracts had stronger associations.

"These results align with prior research consistently demonstrating that individual-level and area-level social determinants compound the risk of adverse health outcomes associated with climate-driven environmental exposures," the authors write.

Two authors disclosed ties to the pharmaceutical and/or medical device industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords